Neurodegenerative Biomarkers in Multiple Sclerosis: At the Interface Between Research and Clinical Practice.
- DOI
- 10.3390/diagnostics15091178
- Published
- 2025 May 6
- Container
- Diagnostics (Basel, Switzerland)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/diagnostics15091178,
title = {Neurodegenerative Biomarkers in Multiple Sclerosis: At the Interface Between Research and Clinical Practice.},
author = {Ciubotaru A and Smihor MI and Grosu C and Alexa D and Covali R and Anicăi RC and Păvăleanu I and Cucu AI and Bobu AM and Ghiciuc CM and Ignat EB},
year = {2025},
journal = {Diagnostics (Basel, Switzerland)},
doi = {10.3390/diagnostics15091178},
url = {https://doi.org/10.3390/diagnostics15091178}
}RIS
TY - JOUR TI - Neurodegenerative Biomarkers in Multiple Sclerosis: At the Interface Between Research and Clinical Practice. AU - Ciubotaru A AU - Smihor MI AU - Grosu C AU - Alexa D AU - Covali R AU - Anicăi RC AU - Păvăleanu I AU - Cucu AI AU - Bobu AM AU - Ghiciuc CM AU - Ignat EB PY - 2025 JO - Diagnostics (Basel, Switzerland) DO - 10.3390/diagnostics15091178 UR - https://doi.org/10.3390/diagnostics15091178 ER -
APA
A, C., MI, S., C, G., D, A., R, C., RC, A., I, P., AI, C., AM, B., CM, G., & EB, I. (2025). Neurodegenerative Biomarkers in Multiple Sclerosis: At the Interface Between Research and Clinical Practice.. Diagnostics (Basel, Switzerland). https://doi.org/10.3390/diagnostics15091178
Source records
- pubmed · retrieved 2026-11-10T09:34:50.482Z